Association of Mitochondrial DNA Polymerase γ Gene POLG1 Polymorphisms with Parkinsonism in Chinese Populations

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Gui, Ya xing ^a   Xu, Zhong ping ^c   Lv, Wen ^a   Liu, Hong mei ^b   Zhao, Jin Jia ^a   Hu, Xing Yue ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE GAMMA; MESSENGER RNA;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CAG REPEAT; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; POLG1 GENE; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DNA-DIRECTED DNA POLYMERASE; FEMALE; GENE FREQUENCY; GENES, MITOCHONDRIAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MITOCHONDRIA; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84870906552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050086     Document Type: Article

References (31)

1. Samii A, Nutt JG, Ransom BR, (2004) Parkinson's disease. Lancet 363: 1783-1793.
2. Davie CA, (2008) A review of Parkinson's disease. Br Med Bull 86: 109-127.
3. Westerlund M, Hoffer B, Olson L, (2010) Parkinson's disease: Exit toxins, enter genetics. Prog Neurobiol 90: 146-156.
4. Bereznai B, Molnar MJ, (2009) [Genetics and present therapy options in Parkinson's disease: a review]. Ideggyogy Sz 62: 155-163.
5. Di Fonzo A, Bordoni A, Crimi M, Sara G, Del Bo R, et al. (2003) POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions. Hum Mutat 22: 498-499.
6. Eerola J, Luoma PT, Peuralinna T, Scholz S, Paisan-Ruiz C, et al. (2010) POLG1 polyglutamine tract variants associated with Parkinson's disease. Neurosci Lett 477: 1-5.
7. Luoma PT, Eerola J, Ahola S, Hakonen AH, Hellstrom O, et al. (2007) Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 69: 1152-1159.
8. Hudson G, Schaefer AM, Taylor RW, Tiangyou W, Gibson A, et al. (2007) Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch Neurol 64: 553-557.
9. Orsucci D, Caldarazzo Ienco E, Mancuso M, Siciliano G, (2011) POLG1-related and other "mitochondrial Parkinsonisms": an overview. J Mol Neurosci 44: 17-24.
10. Spelbrink JN, Toivonen JM, Hakkaart GA, Kurkela JM, Cooper HM, et al. (2000) In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J Biol Chem 275: 24818-24828.
11. Graziewicz MA, Longley MJ, Copeland WC, (2006) DNA polymerase gamma in mitochondrial DNA replication and repair. Chem Rev 106: 383-405.
12. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, et al. (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423.
13. Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, et al. (2006) Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 59: 859-862.
14. Remes AM, Hinttala R, Karppa M, Soini H, Takalo R, et al. (2008) Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism Relat Disord 14: 652-654.
15. Anvret A, Westerlund M, Sydow O, Willows T, Lind C, et al. (2010) Variations of the CAG trinucleotide repeat in DNA polymerase gamma (POLG1) is associated with Parkinson's disease in Sweden. Neurosci Lett 485: 117-120.
16. Deuschl G, Bain P, Brin M, (1998) Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 13 Suppl 3: 2-23.
17. Bai RK, Wong LJ, (2004) Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem 50: 996-1001.
18. Grzesiak JJ, Smith KC, Chalberg C, Truong C, Burton DW, et al. (2005) Heat shock protein-70 expressed on the surface of cancer cells binds parathyroid hormone-related protein in vitro. Endocrinology 146: 3567-3576.
19. Bruggenwirth HT, Boehmer AL, Ramnarain S, Verleun-Mooijman MC, Satijn DP, et al. (1997) Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. Am J Hum Genet 61: 1067-1077.
20. Fujimaru M, Tanaka A, Choeh K, Wakamatsu N, Sakuraba H, et al. (1998) Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3′-splice site selection and cause Sandhoff disease. Hum Genet 103: 462-469.
21. Yu C, Meng X, Zhang S, Zhao G, Hu L, et al. (2003) A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family. Genomics 82: 575-579.
22. de Almeida SF, Carmo-Fonseca M, (2012) Design principles of interconnections between chromatin and pre-mRNA splicing. Trends Biochem Sci 37: 248-253.
23. Montes M, Becerra S, Sanchez-Alvarez M, Sune C, (2012) Functional coupling of transcription and splicing. Gene 501: 104-117.
24. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312.
25. Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, et al. (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124: 593-605.
26. Hudson G, Tiangyou W, Stutt A, Eccles M, Robinson L, et al. (2009) No association between common POLG1 variants and sporadic idiopathic Parkinson's disease. Mov Disord 24: 1092-1094.
27. Moyer RA, Wang D, Papp AC, Smith RM, Duque L, et al. (2011) Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology 36: 753-762.
28. Wang D, Guo Y, Wrighton SA, Cooke GE, Sadee W, (2011) Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J 11: 274-286.
29. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, et al. (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37: e67.
30. Rigo F, Martinson HG, (2008) Functional coupling of last-intron splicing and 3′-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage. Mol Cell Biol 28: 849-862.
31. Michlewski G, Sanford JR, Caceres JF, (2008) The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1. Mol Cell 30: 179-189.